Taikang Asset Management (HK)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,975
| Closed | -$2.88M | – | 111 |
|
|
2025
Q4 | $2.88M | Sell |
4,975
-5,769
| -54% | -$3.26M | 0.29% | 80 |
|
|
2025
Q3 | $5.21M | Buy |
10,744
+3,528
| +49% | +$1.64M | 0.58% | 48 |
|
|
2025
Q2 | $2.93M | Hold |
7,216
| – | – | 0.38% | 77 |
|
|
2025
Q1 | $3.59M | Sell |
7,216
-10,300
| -59% | -$5.58M | 0.49% | 63 |
|
|
2024
Q4 | $9.11M | Buy |
17,516
+3,084
| +21% | +$1.7M | 1.34% | 17 |
|
|
2024
Q3 | $8.93M | Buy |
14,432
+7,216
| +100% | +$4.27M | 0.94% | 35 |
|
|
2024
Q2 | $3.99M | Hold |
7,216
| – | – | 0.62% | 40 |
|
|
2024
Q1 | $4.19M | Buy |
7,216
+523
| +8% | +$293K | 0.88% | 31 |
|
|
2023
Q4 | $3.55M | Hold |
6,693
| – | – | 0.67% | 34 |
|
|
2023
Q3 | $26.5M | Hold |
6,693
| – | – | 0.77% | 31 |
|
|
2023
Q2 | $27.4M | Sell |
6,693
-6,693
| -50% | -$3.61M | 0.81% | 31 |
|
|
2023
Q1 | $60.6M | Buy |
13,386
+7,748
| +137% | +$4.37M | 1.4% | 26 |
|
|
2022
Q4 | $24.2M | Sell |
5,638
-12,834
| -69% | -$6.8M | 0.65% | 51 |
|
|
2022
Q3 | $73.5M | Hold |
18,472
| – | – | 1.93% | 17 |
|
|
2022
Q2 | $78.7M | Sell |
18,472
-134
| -0.7% | -$73.8K | 1.94% | 16 |
|
|
2022
Q1 | $11M | Buy |
18,606
+9,236
| +99% | +$5.31M | 1.87% | 14 |
|
|
2021
Q4 | $6.25M | Hold |
9,370
| – | – | 1.24% | 16 |
|
|
2021
Q3 | $5.35M | Hold |
9,370
| – | – | 1.09% | 17 |
|
|
2021
Q2 | $4.73M | Hold |
9,370
| – | – | 0.73% | 28 |
|
|
2021
Q1 | $4.28M | Hold |
9,370
| – | – | 0.81% | 26 |
|
|
2020
Q4 | $4.36M | Buy |
9,370
+1,062
| +13% | +$498K | 0.64% | 24 |
|
|
2020
Q3 | $3.67M | Buy |
8,308
+134
| +2% | +$55.4K | 0.57% | 28 |
|
|
2020
Q2 | $2.96M | Buy |
8,174
+91
| +1% | +$30.5K | 0.53% | 35 |
|
|
2020
Q1 | $2.29M | Buy |
8,083
+1,252
| +18% | +$395K | 0.52% | 35 |
|
|
2019
Q4 | $2.22M | Hold |
6,831
| – | – | 0.56% | 32 |
|
|
2019
Q3 | $1.99M | Hold |
6,831
| – | – | 0.22% | 36 |
|
|
2019
Q2 | $2.01M | Hold |
6,831
| – | – | 0.23% | 29 |
|
|
2019
Q1 | $1.87M | Hold |
6,831
| – | – | 0.26% | 26 |
|
|
2018
Q4 | $1.53M | Buy |
6,831
+940
| +16% | +$221K | 0.26% | 29 |
|
|
2018
Q3 | $1.44M | Hold |
5,891
| – | – | 0.18% | 37 |
|
|
2018
Q2 | $1.22M | Buy |
5,891
+1,522
| +35% | +$323K | 0.14% | 49 |
|
|
2018
Q1 | $902K | Buy |
4,369
+3,118
| +249% | +$654K | 0.09% | 46 |
|
|
2017
Q4 | $238K | Buy |
+1,251
| New | +$240K | 0.03% | 62 |
|
Other funds holding TMO
VCM
Taikang Asset Management (HK)'s TMO Position: Q1 2026 in Review
Taikang Asset Management (HK) sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 4,975 shares — an estimated $2.88M sold.
Taikang Asset Management (HK) first reported a position in TMO in Q4 2017 and held it in 33 quarters. The position peaked at $78.7M in Q2 2022. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Taikang Asset Management (HK) reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- Taikang Asset Management (HK) sold 4,975 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.88M.
- Taikang Asset Management (HK) first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 33 quarters.
- Taikang Asset Management (HK)'s Thermo Fisher Scientific position peaked at $78.7M in Q2 2022.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Taikang Asset Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.